A Cost That's Hard to (G)u(LP-1) Down
US$ 27.63
glp-1 weight loss drug news november 2025 The GLP-1 Access Gap: Mapping Who Can Actually Afford America's Chart: 1 in 8 Americans
Description
Noom is partnering with an academic institution to study the results of a microdosing program
Economic burden of obesity: a systematic literature review
This medication is not available in New Zealand
Will track that
Not everyone should or needs to take GLP-1 for weight loss or health care
For most GLP-1 weight management medications, Anthem requires a BMI of 30 or greater (clinical obesity) or a BMI of 27 or greater with at least one weight-related comorbidity
